CoChat

The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.

Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer

Open access

Abstract

Radiation resistance in breast cancer resulting in residual lesions or recurrence is a significant cause to radiotherapy failure. Cancer‐associated fibroblasts (CAFs) and radiotherapy‐induced senescent CAFs can further lead to radiation resistance and tumor immunosuppressive microenvironment. Here, an engineering cancer‐cell‐biomimetic nanoplatform is constructed for dual‐targeted clearance of CAFs as well as senescent CAFs. The nanoplatform is prepared by 4T1 cell membrane vesicles chimerized with FAP single‐chain fragment variable as the biomimetic shell for targeting of CAFs and senescent CAFs, and PLGA nanoparticles (NPs) co‐encapsulated with nintedanib and ABT‐263 as the core for clearance of CAFs and senescent CAFs, which are noted as FAP‐CAR‐CM@PLGA‐AB NPs. It is evidenced that FAP‐CAR‐CM@PLGA‐AB NPs directly suppressed the tumor‐promoting effect of senescent CAFs. It also exhibits prolonged blood circulation and enhanced tumor accumulation, dual‐cleared CAFs and senescent CAFs, improved radiation resistance in both acquired and patient‐derived radioresistant tumor cells, and effective antitumor effect with the tumor suppression rate of 86.7%. In addition, FAP‐CAR‐CM@PLGA‐AB NPs reverse the tumor immunosuppressive microenvironment and enhance systemic antitumor immunity. The biomimetic system for dual‐targeted clearance of CAFs and senescent CAFs provides a potential strategy for enhancing the radio‐sensitization of breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/smll.202309279

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 3

  1. Loganadane G., 2017, Clin. Transl. Radiat. Oncol., 4, 46
  2. Liu A., 2013, Chin. J. Cancer., 32, 483
  3. Pagar R. R., 2022, ACS Appl. Bio Mater., 8, 2161

Cited by

See all 38

Metadata

Authors
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C.
Affiliations
  • Wuhan Union Hospital (CN)
  • Shanghai Jiao Tong University (CN)
  • Department of Pharmacy Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430022 China
Venue
Small
Publisher
Wiley
Published
2024-01-12
Volume
20
Issue
25
Pages
e2309279-e2309279
ISSN
  • 1613-6810 (ISSN-L)
  • 1613-6829
OpenAlex
W4390795819
Cited by
33
References
63
Citations by year
2026: 14 · 2025: 11 · 2024: 8
FWCI
3.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Small (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (82073402, 81901884, 82272821)
  • Natural Science Foundation of Shanghai Municipality (22ZR1467600)
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
cancer-associated fibroblasts, radioresistance (biology), breast cancer, biomimetic nanoplatform, cell membrane vesicles, PLGA nanoparticles, nintedanib, navitoclax, radiosensitization, immunosuppressive tumor microenvironment, tumor microenvironment
MeSH terms
Cancer-Associated Fibroblasts, Polylactic Acid-Polyglycolic Acid Copolymer, Animals, Breast Neoplasms, Female, Humans, Radiation Tolerance, Cellular Senescence, Biomimetics, Biomimetic Materials, Cell Line, Tumor, Mice, Nanoparticles, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. https://app.cochat.ai/papers/10.1002/smll.202309279
The paper
Jian, C., Wu, T., Wang, L., Gao, C., Fu, Z., Zhang, Q., & Shi, C. (2024). Biomimetic Nanoplatform for Dual‐Targeted Clearance of Activated and Senescent Cancer‐Associated Fibroblasts to Improve Radiation Resistance in Breast Cancer. Small. https://doi.org/10.1002/smll.202309279

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.